Global DNA Probes-Based Diagnostics Strategic Business Report 2015-2022 - Research and Markets
DUBLIN, August 30, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "DNA Probes-Based Diagnostics - Global Strategic Business Report" report to their offering.
This report analyzes the worldwide markets for DNA Probes-Based Diagnostics in US$ Million by the following Application Areas: Infectious Diseases, Cancer Testing, Genetic Predisposition, Identity/Forensics, and Others.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
The report profiles 46 companies including many key and niche players such as
- Abbott Molecular (USA)
- Affymetrix, Inc. (USA)
- Beckman Coulter, Inc. (USA)
- Becton, Dickinson and Company (USA)
- bioMérieux (France)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- GE Healthcare Life Sciences (UK)
- Luminex Corporation (USA)
- QIAGEN N.V. (Netherlands)
- Siemens Healthineers (Germany)
Key Topics Covered:
1. MARKET DYNAMICS What are DNA-Probes?
DNA-based Diagnostics A Prelude DNA Tests:
Finding Use in Numerous Applications DNA Probes:
Robust Growth Ahead Developed Markets:
Traditional Revenue Contributors The United States:
Unraveling the Country's Edge in DNA-based Diagnostics Infectious Diseases Tests Dominate the DNA-based Diagnostics Market
Developing Countries Excel in Growth Prospects Decoding the Genetic Puzzle Advantages of DNA-Probe
Tests Growth Drivers in a Nutshell Growth Inhibitors in a Nutshell Genetic Profiling of Pathogens:
A Road Less Traveled Roche's Entry into the Hall of Molecular Fame DNA Technology:
An Evolutionary Scan Tracking Landmark Breakthroughs in DNA Diagnostics: 1953-2005 Market Opportunities
2. MARKET DRIVERS AND TRENDS
World's Aging Population Drives the Popularity of DNA-Probe Tests
Global Aging Population Statistics
Opportunity Indicators
Rising Incidence of Chronic Diseases Fuels Demand for DNA Probes Based Diagnostics
AIDS: A Global Epidemic
Facts & Figures
Reimbursements: Under the Umbrella
Evolution of New & Virulent Infectious Agents
Challenges in Widespread Deployment of DNA-based Diagnostics
Improvements in Assay Capabilities
Information Handling & Processing: The Soft Side of Diagnostics
Integration: The Ultimate Challenge
DNA Probe Technology Gains Prominence in Diagnosing Vaginitis
Gene Banks
A Ray of Hope for the Future
3. DNA PROBES-BASED DIAGNOSTICS
- A PRIMER Diagnostic Gene Detection Products Molecular Diagnostics:
A Powerful Disease Detection Tool DNA Probes-Based Products Direct Detection of Target Sequence
Nucleic Acid Amplification Gene Detection Using DNA Chips Gene Detection by DNA Sequencing
The Dynamics of Key Enabling Technologies Polymerase Chain Reaction (PCR) In situ Hybridization Chemiluminescence
Gen-Probe Tigris DNA Chips Molecular Diagnostics
A Primer Implications for Clinical Diagnostics Need of the Hour Impact of the Human Genome Project Tailored Patient Management:
An Epitomized Future of Molecular Diagnostics Outlook
4. PRODUCT OVERVIEW
Background
Gene Probe Technology
What is DNA?
DNA Probes
Miniaturization: A Revolutionary Method in DNA Analysis
Gene Chip Technology
DNA Chips
Chromosome Painting Probes
Diagnostic Applications Based on DNA Probes: An Overview
Infectious Diseases
Respiratory Tract Infections
Diagnosis of Mycoplasma
DNA Probes to Detect Legionella Pneumophila
Detecting Tuberculosis through Rapid Diagnostic Tests
How the Technique Works
Limitations
Sexually Transmitted Diseases (STDs)
HIV
HTLV-1 Testing
Hepatitis Testing
Chlamydia DNA Probes
Detection of Intestinal Parasites
Entamoeba Histolytica
Salmonella
Malaria Testing
Identity/Forensics
DNA Profiling: A Key Forensic Tool
DNA-Based Forensic Diagnostics
Tracing Human Origins
Genetic Predisposition
Molecular HLA Testing
Human Leukocyte Antigen (HLA) Typing
Cancer Testing
Cancer: A Deadly Disease Afflicting Millions
Slow Detoxifiers: Potential Cancer Candidates
Improving Cancer Surgery through Diagnostic Tests
Types of Cancer
Chronic Lymphocytic Leukemia (CLL)
Breast Cancer
PCR Screening Technology for Breast Cancer
Eye Cancers
DNA Probes to Detect Retinoblastoma
Others
The Ames test
Genetic Testing
Other Diagnostic Applications
Cystic Fibrosis
Duchenne's Muscular Dystrophy
Huntington's Disease
Diabetes
Detection of Multidrug Resistance
Bacterial Resistance to Antibiotics
5. PRODUCT INTRODUCTIONS/INNOVATIONS DLCS
Unveils In-House DNA Fish Test for Melanoma Agilent Technologies Introduces
New SureFISH Break-Apart Probes Beckman Coulter Life Sciences Rolls Out PerFix-Expose1 and PerFix-nc1
6. RECENT INDUSTRY ACTIVITY
Thermo Fisher Scientific Acquires Affymetrix
Illumina Partners with Memorial Sloan Kettering
Cancer Genetics to Acquire BioServe Biotechnologies
Co-Diagnostics to Acquire DNA Logix' Technologies
Leica Biosystems Takes Over Kreatech Diagnostics and Aotec
7. FOCUS ON SELECT GLOBAL PLAYERS
Abbott Molecular (USA) Affymetrix, Inc. (USA)
Beckman Coulter, Inc. (USA)
Becton, Dickinson and Company (USA)
bioMérieux (France)
F. Hoffmann-La Roche Ltd. (Switzerland)
GE Healthcare Life Sciences (UK)
Luminex Corporation (USA)
QIAGEN N.V. (Netherlands)
Siemens Healthineers (Germany)
8. GLOBAL MARKET PERSPECTIVE
Total Companies Profiled: 46 (including Divisions/Subsidiaries 57)
- The United States (37)
- Canada (2)
- Japan (1)
- Europe (13)
- - France (1)
- - Germany (3)
- - The United Kingdom (2)
- - Italy (1)
- - Spain (1)
- - Rest of Europe (5)
- Asia-Pacific (Excluding Japan) (4)
For more information about this report visit http://www.researchandmarkets.com/research/rmrkcf/dna_probesbased
Related Topics: Diagnostics
Media Contact:
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article